Cyclosporin and the gingival tissues

Area of Science:

• Pharmacology
• Immunology
• Oral Medicine

Background:

• Cyclosporin is a widely used selective immunosuppressant.
• The drug is known to cause gingival overgrowth, similar to phenytoin and calcium channel blockers.

Purpose of the Study:

• To review the pharmacokinetics, pharmacodynamics, uses, and adverse effects of cyclosporin.
• To specifically examine the drug's impact on gingival tissues and the mechanism of cyclosporin-induced gingival overgrowth.

Main Methods:

• Review of existing clinical and cell culture studies.
• Analysis of pharmacokinetic and pharmacodynamic data.
• Examination of drug interactions with gingival fibroblasts.

Main Results:

• Cyclosporin and its metabolites interact with gingival fibroblasts.
• This interaction is implicated in the mechanism of gingival overgrowth.
• Plaque-induced gingival inflammation may exacerbate the drug's effect on gingival tissues.

Conclusions:

• The mechanism of cyclosporin-induced gingival overgrowth involves drug-fibroblast interactions.
• Gingival inflammation can potentiate this adverse effect.
• Understanding this mechanism is crucial for managing cyclosporin therapy.